Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 7:39:100576.
doi: 10.1016/j.ctro.2023.100576. eCollection 2023 Mar.

Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer

Affiliations

Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer

Yusuke Uchinami et al. Clin Transl Radiat Oncol. .

Abstract

Background: The aim of this study is to quantify the short-term motion of the gastrointestinal tract (GI-tract) and its impact on dosimetric parameters in stereotactic body radiation therapy (SBRT) for pancreatic cancer.

Methods: The analyzed patients were eleven pancreatic cancer patients treated with SBRT or proton beam therapy. To ensure a fair analysis, the simulation SBRT plan was generated on the planning CT in all patients with the dose prescription of 40 Gy in 5 fractions. The GI-tract motion (stomach, duodenum, small and large intestine) was evaluated using three CT images scanned at spontaneous expiration. After fiducial-based rigid image registration, the contours in each CT image were generated and transferred to the planning CT, then the organ motion was evaluated. Planning at risk volumes (PRV) of each GI-tract were generated by adding 5 mm margins, and the volume receiving at least 33 Gy (V33) < 0.5 cm3 was evaluated as the dose constraint.

Results: The median interval between the first and last CT scans was 736 s (interquartile range, IQR:624-986). To compensate for the GI-tract motion based on the planning CT, the necessary median margin was 8.0 mm (IQR: 8.0-10.0) for the duodenum and 14.0 mm (12.0-16.0) for the small intestine. Compared to the planned V33 with the worst case, the median V33 in the PRV of the duodenum significantly increased from 0.20 cm3 (IQR: 0.02-0.26) to 0.33 cm3 (0.10-0.59) at Wilcoxon signed-rank test (p = 0.031).

Conclusion: The short-term motions of the GI-tract lead to high dose differences.

Keywords: 4DCT, four-dimensional computed tomography,; CTV, clinical target volume; FFF, flattening filter-free; GI-tract, gastrointestinal tract; GTV, gross tumor volume; Gastrointestinal tract; IQR, interquartile range; Intra-fractional motion; MV, mega-voltage; PRV, planning at risk volume; PTV, planning target volume; Pancreatic cancer; ROI, region of interest; SBRT; SBRT, stereotactic body radiation therapy; SD, standard deviation; Short-term organ motion; VMAT, volumetric modulated arc therapy.

PubMed Disclaimer

Conflict of interest statement

K.K. is an employee of the research institute of Hitachi, Ltd., currently working at Hokkaido University, under a secondary agreement. K.K. declares that this research has no relationship with Hitachi, Ltd. All other authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
(A) The method of target or organ contouring and (B) the method of quantifying the minimum margin to compensate for ROI at the planning CT scan. A (a): Three different CT images (CTp, CTCE, and CT4D) were prepared. (b) The CTCE and CT4D images were rigidly registered based on the vertebral bone for the CTP, then translation-only registration was performed based on the fiducial marker position. (c) Target or organ contours in CTP (ROIP) were deformably transferred to the CTCE or CT4D, then transferred back to the CTP after review and modification of deformed contours. Each region of interest (ROI) on CT images are shown as ROIP, ROICE and ROI4D. (d) Analysis was performed on the CTp using ROIP, ROICE, and ROI4D. B (a): ROIs in CTP, CT4D, and CTCE are termed as ROIP, ROICE, and ROI4D. (b) The sum of all contours is defined as the ROIall. (c) To evaluate the margin to compensate for ROIall, margins were determined every 2 mm from the ROIP to the entire circumference. In this example, the minimum margin is calculated to be 6 mm. ROI: region of interest.
Fig. 2
Fig. 2
The GI-tract motion of a case after fiducial-based image registration. The contour of the stomach (blue), duodenum (pink), small intestine (green), and large intestine (purple) are shown on each of the CT images (a-c). The contours of three CT images are simultaneously shown superimposed on the CTP in panel (d), which indicates variations of GI-tract location. GI-tract: gastrointestinal tract. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3
Fig. 3
Box plot of the necessary margins to compensate for motion in the contoured GI-tracts. Boxes show the interquartile range from 25 to 75 %ile. Median values and outliers are shown as horizontal lines within the box and black circles. GI-tract: gastrointestinal tract.

References

    1. Chuong M.D., Springett G.M., Freilich J.M., Park C.K., Weber J.M., Mellon E.A., et al. Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated. International Journal of Radiation Oncology*Biology*Physics. 2013;86(3):516–522. - PubMed
    1. de Geus S.W.L., Eskander M.F., Kasumova G.G., Ng S.C., Kent T.S., Mancias J.D., et al. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Cancer. 2017;123(21):4158–4167. - PubMed
    1. Herman J.M., Chang D.T., Goodman K.A., Dholakia A.S., Raman S.P., Hacker‐Prietz A., et al. Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma. Cancer. 2015;121(7):1128–1137. - PMC - PubMed
    1. Hoyer M., Roed H., Sengelov L., Traberg A., Ohlhuis L., Pedersen J., et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol. 2005;76(1):48–53. - PubMed
    1. Jiang W., Haque W., Verma V., Butler E.B., Teh B.S. Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma. Acta Oncol. 2019;58(9):1259–1266. - PubMed

LinkOut - more resources